Vliyanie kureniya na effektivnost' kardiovaskulyarnykh preparatov
- Authors: Leonova M.V1
-
Affiliations:
- ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ
- Issue: Vol 15, No 1 (2013)
- Pages: 50-55
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/93758
- ID: 93758
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. V Leonova
ГБОУ ВПО Российский национальный исследовательский медицинский университет им. Н.И.Пирогова Минздрава РФ
References
- Мировая статистика здравоохранения. Женева. ВОЗ. 2007.
- Демографический ежегодник России. Статистический сборник. М., 2001.
- Систематический подход к отказу от курения. Материалы семинара. Американский международный союз здравоохранения. Агентство США по международному развитию при технической поддержке центров по контролю над заболеваниями и профилактике. США. М., 2002.
- William B, White. Smoking - related morbidity and mortality in the cardiovascular setting. Prev Cardiol 2007; 10 (2 Suppl. 1): 1–4.
- Campisi R, Сzernin J, Schoder H et al. Effects of long - term smoking on myocardial blood flow, coronary vasomotion and vasodilator capacity. Circulation 1998; 98: 119–25.
- Оганов Р.Г., Деев А.Д., Жуковский Г.С. и др. Влияние курения на смертность от хронических неинфекционных заболеваний, по результатам проспективного исследования. Профилактика заболеваний и укрепление здоровья. 1998; 3: 13–5.
- Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115: 242–9.
- Hankey G.J. Smoking and risk of stroke. J Cardiovasc Risk 1999; 6: 207–11.
- Лукина Ю.В. Лекарственные препараты и курение. Рацион. фармакотерапия в кардиологии. 2005; 1: 31–6.
- Сахарова Г.М., Чучалин А.Г. Лечение табачной зависимости. РМЖ. 2001; 9 (5): 168–73.
- Barry J, Mead K, Nabel E.G. Effect of smoking on the activity of ischemic heart disease. JAMA 1989; 261 (3): 398–402.
- Hanna S.T. Nicotin effect on cardiovascular system and ion channel. J Cardiovasc Pharmacol 2006; 47 (3): 348–58.
- Ambrose J.A., Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease. An update. J Am Coll Cardiol 2004; 43: 1731–7.
- Rahman M.M., Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007; 5 (4): 276–92.
- Toda N, Toda H. Nitric oxide - mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol 2010; 649 (1–3): 1–13.
- Raupach T, Schäfer K, Konstantinides S, Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 2006; 27 (4): 386–92.
- Hung L, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patient with coronary disease taking aspirin. Circulation 1995; 92: 2432–6.
- De Cesaris R, Raniery G, Filliti V et al. Cardiovascular effects of cigarette smoking. Br J Clin Pharmacol 1987; 24 (2): 173–8.
- Bang L.E., Buttenschon L, Kristensen K.S., Svedsen T.L. Do we undertreat hypertensive smokers? A comparison between smoking and non - smoking hypertensives. Circulation 1994; 90 (1): 248–53.
- Girerd X, Brunel P, Laurent S et al. Effects of beta - blockers on haemodynamics of the forearm after tobacco stimulation. Arch Mal Coeur Vaiss 1988; 81: 133–6.
- Miller L.G. Recent development in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989; 17 (2): 90–108.
- Kimelski R. Interaction between smoking and drugs. Wiad Lek 1986; 39 (1): 31–4.
- Zevin S, Benowitz N.L. Drug interaction with tobacco smoking. An update. Clin Pharmacokinet 1999; 36 (6): 425–38.
- Renwick A.G., Le Vie J, Challenor V.F. et al. Factors affecting the pharmacokinetics of nifedipine. Eur J Clin Pharmacol 1987; 32 (4): 351–5.
- Berkan T, Mead K, Nabel E.G. Effect of smoking on the activity of ischemic heart disease. JAMA 1989; 261 (3): 398–402.
- Luczynska C, Wilson K. The clinical significance of the effects of cigarette smoking on drug disposition. Methods Find Exp Clin Pharmacol 1983; 5 (7): 479–87.
- Walle T, Walle U.K., Coward T.D. et al. Selektive induction of propranolol metabolism by smoking: additional affects on renal clearance of metabolites. J Рharmacol Exp Тher 1987; 241 (3): 928–33.
- Laustiola K.E., Lassila R, Kaprio J, Koskenvuo M. Decreased b - adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation 1988; 78 (Pt. 1): 1234–40.
- Laustiola K.E., Lassila R, Nurmi A.K. Enhanced activation of the renin - angiotensin - aldosterone system in chronic cigarette smokers: a study of monozygotic twin pairs discordant for smoking. Clin Pharmacol Ther 1988; 44 (4): 426–30.
- Leone A. Does Smoking Act as a Friend or Enemy of Blood Pressure? Let Release Pandora’s Box. Cardiology Research and Practice 2011; 1: 1–7.
- The ANBP management committee. The Australian therapeutic trial of mild hypertension. Lancet 1980; 1: 1261–7.
- Kotamaki M, Manninen V, Laustiola K.E. Enalapril versus atenolol in the treatment of hypertensive smokers. Eur J Clin Pharmacol 1993; 44 (1): 13–7.
- Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97–104.
- MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992; 304: 405–12.